A Day Up For Sienna Biopharmaceuticals, Inc.
Mon, Dec 16, 2019 at 05:30 PM
Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ) soared at $0.14, representing a gain of 30.7%. On Fri 13 Dec 19, SNNA:NASDAQ hit a New 2-Week Intraday Low of $0.06. The stock appeared on our News Catalysts scanner on Fri 13 Dec 19 at 12:16 PM in the 'RECOMMENDATION' category. From Fri 22 Nov 19, the stock recorded 28.57% Up Days and 33.33% Green Days
About Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ)
Sienna Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on bringing innovations in biotechnology to the discovery, development and commercialization of targeted, topical products in medical dermatology and aesthetics.
Top 10 Gainers:
- Mirum Pharmaceuticals, Inc. (MIRM:NASDAQ), 110.99%
- Jason Industries, Inc. (JASN:NASDAQ), 90.7%
- Axsome Therapeutics, Inc. (AXSM:NASDAQ), 70.55%
- VistaGen Therapeutics, Inc. (VTGN:NASDAQ), 44.29%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%
- Taoping Inc. (TAOP:NASDAQ), 27.92%
- Verb Technology Company, Inc. (VERB:NASDAQ), 25.93%
- SIFCO Industries, Inc. (SIF:NYSEMKT), 25.56%
- TravelCenters of America Inc. (TA:NASDAQ), 24.41%
- Organovo Holdings, Inc. (ONVO:NASDAQ), 24.12%